tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

3 Best ETFs to Invest In, According to AI Analyst, 01/12/2026

Story Highlights

This article lists three ETFs with an Outperform rating and significant upsides based on TipRanks’ ETF AI analyst’s assessment.

3 Best ETFs to Invest In, According to AI Analyst, 01/12/2026

Exchange-traded funds (ETFs) offer investors a broad and often daunting array of options.

Claim 70% Off TipRanks Premium

TipRanks’ AI analysts pare this universe down to three ETFs with an Outperform rating and significant estimated upsides. The snapshot and chart below provide a concise overview of each fund.

  1. Fundstrat Granny Shots US Large Cap ETF (GRNY)– This fund provides investors with exposure to various sectors, such as technology, industrials, and financials, with the ultimate goal of providing them with growth and stability. It achieves this by focusing on American businesses that are well-established and have large market capitalization. The ETF AI analyst currently has a $28 price target on GRNY, suggesting 9.44% growth potential. The fund’s current Outperform rating comes from strong year-to-date results from Lam Research (LRCX) and Advanced Micro Devices (AMD).
  2. ishares MSCI USA ESG Select ETF (SUSA) — This ETF uses environmental, social, and governance (ESG) factors to filter out businesses that are part of the broader MSCI USA Index. It is designed for investors seeking to balance risk, reward, and environmental responsibility. The ETF AI analyst currently has a $155 price target on SUSA, suggesting 9.36% upside. Outstanding year-to-date performance of several of its largest holdings, including Nvidia (NVDA), Microsoft (MSFT), and Broadcom (AVGO), has earned the fund its current Outperform rating.
  3. iShares U.S. Medical Devices ETF (IHI) As the name suggests, the goal of this ETF is to provide investors with exposure to the most active businesses in the American medical devices industry, including makers of surgical and diagnostic tools. The ETF AI analyst currently has a price target of $69 on IHI, implying 9.37% upside from current trading levels. The fund’s current Outperform rating is carried by strong year-to-date results from key holdings such as Abbott Laboratories (ABT) and Boston Scientific (BSX).

Power up your ETF investing with TipRanks. Discover the Best AI ETFs, carefully curated based on TipRanks’ analysis. 

Disclaimer & DisclosureReport an Issue

1